CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2022-06-08 | Froimson Mark Director | Grant or award | +1,160 | 6,068 | ||
| 2022-06-08 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-05-09 | Froimson Mark Director | Sale | −1,000 | $59.37 | $59K | 4,908 |
| 2021-12-17 | Froimson Mark Director | Gift | −400 | 5,908 | ||
| 2021-06-09 | Froimson Mark Director | Grant or award | +1,066 | 6,308 | ||
| 2021-06-09 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +7,626 | 7,626 | ||
| 2021-03-15 | Froimson Mark Director | Sale | −734 | $72.26 | $53K | 5,242 |
| 2020-06-09 | Froimson Mark Director | Grant or award | +1,260 | 5,976 | ||
| 2020-06-09 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +8,027 | 8,027 | ||
| 2019-12-16 | Froimson Mark Director | Gift | −300 | 4,716 |
Page 2 of 2 · 31 trades